pta20250304067
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR
Venlo (pta067/04.03.2025/22:10 UTC+1) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Roland Sackers |
| 2 | Reason for the notification | |
| a) | Position/status | Member of the managing body |
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | QIAGEN N.V. |
| b) | LEI | 54930036WK3GMCN17Z57 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | NL0015002CX3 | |
| b) | Nature of the transaction | Another |
| Release of 86,400 Performance Stock Units based on grant made on February 28, 2020. Release of 66,740 Performance Stock Units based on grant made on February 28, 2022.Exercise Price: $0. Closing Price on February 28, 2025: $38.40. Subsequent to the grant release, receipt of 79,753 Common Shares upon net share settlement wherein a number of Common Share are withheld by the Company to cover related expenses (such as taxes and transaction costs based on share price on vesting date). Grant of 80,098 Performance Stock Units. Cancellation of 4,260 Performance Stock Units. | ||
| Transaction linked to the exercise of share option programmes | ||
| c) | Price(s) | Volume(s) |
| Not Quantifiable | Not Quantifiable | |
| d) | Aggregated price | Aggregated volume |
| Not Quantifiable | Not Quantifiable | |
| e) | Date of the transaction | 28.02.2025 UTC+1 |
| f) | Place of the transaction | Outside a trading venue |
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0015002CX3 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |